Literature DB >> 33614723

Treatment of Chemotherapy-Induced Subungual Pyogenic Granuloma with Topical Timolol Solution.

Natalie M Williams1, Brian W Morrison1.   

Abstract

INTRODUCTION: Subungual pyogenic granuloma (PG) can be caused by numerous medications including chemotherapeutic agents. These lesions grow rapidly, oftentimes causing significant pain and bleeding, prompting patients to seek treatment. The management of subungual PG ranges from topical steroids to surgical excision. However, patients with chemotherapy-induced PGs are prone to developing multiple or recurrent lesions. Therefore, finding a therapeutic option that effectively eliminates the tumor and prevents the need for repeated procedural interventions is important. The use of topical β-adrenergic antagonists has been reported to be effective in regressing cutaneous PG. CASE
PRESENTATION: In this report, we present a case of chemotherapy-induced subungual PG of the toenail arising in a 62-year-old woman that was successfully treated with topical timolol solution.
CONCLUSION: This case highlights the promising use of timolol solution for therapeutically challenging PGs, such as those of subungual regions. This option may be particularly useful for individuals who are vulnerable to multiple PGs secondary to chemotherapy who wish to avoid repeated procedural interventions.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Nail pathology; Pyogenic granuloma; Tumor

Year:  2020        PMID: 33614723      PMCID: PMC7879307          DOI: 10.1159/000511470

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  9 in total

Review 1.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 2.  Periungual and subungual pyogenic granuloma.

Authors:  B M Piraccini; S Bellavista; C Misciali; A Tosti; D de Berker; B Richert
Journal:  Br J Dermatol       Date:  2010-11       Impact factor: 9.302

3.  Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patients.

Authors:  B M Piraccini; A Alessandrini; E Dika; M Starace; A Patrizi; I Neri
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-02-23       Impact factor: 6.166

4.  The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry.

Authors:  K Yuan; Y T Jin; M T Lin
Journal:  J Periodontol       Date:  2000-05       Impact factor: 6.993

5.  Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.

Authors:  Xavier Cubiró; Sergi Planas-Ciudad; Mª Pilar Garcia-Muret; Lluís Puig
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

6.  Is timolol an effective treatment for pyogenic granuloma?

Authors:  Divya Gupta; Nidhi Singh; Devinder Mohan Thappa
Journal:  Int J Dermatol       Date:  2016-02-12       Impact factor: 2.736

7.  β-Adrenergic receptor expression in vascular tumors.

Authors:  Karen M Chisholm; Kay W Chang; Mai T Truong; Shirley Kwok; Rob B West; Amy E Heerema-McKenney
Journal:  Mod Pathol       Date:  2012-06-29       Impact factor: 7.842

8.  Periungual pyogenic granuloma formation in a patient with complex regional pain syndrome.

Authors:  Rachel Resenstein; Stephen Lewellis; Marie Leger
Journal:  Dermatol Online J       Date:  2015-12-16

9.  Treatment of pediatric pyogenic granulomas using β-adrenergic receptor antagonists.

Authors:  Lara Wine Lee; Kiera L Goff; Joseph M Lam; David W Low; Albert C Yan; Leslie Castelo-Soccio
Journal:  Pediatr Dermatol       Date:  2013-10-21       Impact factor: 1.588

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.